Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.

about

Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.

Item

http://www.wikidata.org/entity/Q39308370

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Clinical Outcome of Patients w ...... for Advanced Germ Cell Tumors.

@en

Clinical Outcome of Patients w ...... for Advanced Germ Cell Tumors.

@nl

type

Item

label

Clinical Outcome of Patients w ...... for Advanced Germ Cell Tumors.

@en

Clinical Outcome of Patients w ...... for Advanced Germ Cell Tumors.

@nl

prefLabel

Clinical Outcome of Patients w ...... for Advanced Germ Cell Tumors.

@en

Clinical Outcome of Patients w ...... for Advanced Germ Cell Tumors.

@nl

P1476

Clinical Outcome of Patients w ...... for Advanced Germ Cell Tumors.

@en

P2093

Brett S Carver

http://www.w3.org/2001/XMLSchema#string

Dean F Bajorin

http://www.w3.org/2001/XMLSchema#string

George J Bosl

http://www.w3.org/2001/XMLSchema#string

Joel Sheinfeld

http://www.w3.org/2001/XMLSchema#string

Maria F Becerra

http://www.w3.org/2001/XMLSchema#string

Robert J Motzer

http://www.w3.org/2001/XMLSchema#string

Roy Mano

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular genetic evidence supporting the neoplastic nature of stromal cells in 'fibrosis' after chemotherapy for testicular germ cell tumours.

The role of retroperitoneal lymph node dissection in the management of testicular cancer.

Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?

Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.

Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?

Epidemiology and Diagnosis of Testis Cancer.

The Role of Postchemotherapy Surgery in Germ Cell Tumors.

Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?

Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.

Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections.

P304

391-397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2016.09.113

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

197

http://www.w3.org/2001/XMLSchema#string

P50

Darren R Feldman

P577

2016-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27720783

http://www.w3.org/2001/XMLSchema#string

P921

lymph node

P932

5241176

http://www.w3.org/2001/XMLSchema#string